Position in ALVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,328
-$4,809 QoQ
Shares Held
3,612
-31.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 72 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. ALVO ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
111,351 | $3,860,538 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,880 | $2,102,300 | |
| 3 | ZTS |
Zoetis Inc.
|
24,069 | $1,729,598 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,270 | $1,225,285 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
38,301 | $942,587 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
6,773 | $751,395 | |
| 7 | ALKS |
Alkermes plc.
|
6,157 | $322,626 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
7,032 | $288,522 |
All Filings in ALVO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,328 | 3,612 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $18,137 | 5,288 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,159 | 3,345 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,581 | 6,176 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,446 | 1,913 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $80,522 | 8,327 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,713 | 961 | Shares | Other | 2025-02-13 | |
| 2022-09-30 | $6,780 | 1,003 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $20,418 | 2,487 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||